Cargando…
Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge
Highly pathogenic avian influenza H5N1 infection remains a public health threat and vaccination is the best measure of limiting the impact of a potential pandemic. Mucosal vaccines have the advantage of eliciting immune responses at the site of viral entry, thereby preventing infection as well as fu...
Autores principales: | Major, Diane, Chichester, Jessica A, Pathirana, Rishi D, Guilfoyle, Kate, Shoji, Yoko, Guzman, Carlos A, Yusibov, Vidadi, Cox, Rebecca J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514375/ https://www.ncbi.nlm.nih.gov/pubmed/25714901 http://dx.doi.org/10.4161/21645515.2014.988554 |
Ejemplares similares
-
Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets
por: Cox, Rebecca J., et al.
Publicado: (2015) -
A plant‐produced influenza subunit vaccine protects ferrets against virus challenge
por: Mett, Vadim, et al.
Publicado: (2008) -
A plant‐based system for rapid production of influenza vaccine antigens
por: Shoji, Yoko, et al.
Publicado: (2011) -
The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants
por: Jul-Larsen, Åsne, et al.
Publicado: (2012) -
Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults
por: Chichester, Jessica A., et al.
Publicado: (2012)